Skip to main content
. 2016 Mar;8(Suppl 3):S258–S264. doi: 10.3978/j.issn.2072-1439.2016.02.42

Table 1. Clinical characters.

Case Age (years) Sex Tumor size (centimeters) WHO classification Involved organs Postoperative complications
1 61 M 3.0×2.5×2.0 B2 P N
2* 56 M 4.0×3.5×3.0 B1 P N
3 47 M 7.5×6.5×4.0 B2 P N
4 54 M 7.0×3.0×3.0 B2–B3 P N
5* 44 M 6.0×4.0×3.0 B2–B3 RUL MC
6 45 F 7.0×6.5×4.0 B1 P N
7 45 F 6.0×5.5×3.0 AB P N
8 69 M 6.0×6.0×5.0 B2–B3 P AF
9* 70 M 6.0×5.0×5.0 B2–B3 P N
10* 53 M 3.0×2.0×2.0 B1–B2 RUL N
11 67 M 5.0×4.0×3.0 B2–B3 LIV N
12* 52 F 4.0×4.0×4.0 B2–B3 P N
13 46 M 5.0×4.0×3.0 B2–B3 P, LIV N

*, Co-morbidity: ocular myasthenia gravis. F, female; M, male; WHO, World Health Organization; RUL, right upper lobe; LIV, left innominate vein; P, pericardium; N, none; MC, myasthenic crisis; AF, atrial fibrillation.